Publication:
Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia

dc.contributor.authorAlvarez-Fuente, Maria
dc.contributor.authorMoreno, Laura
dc.contributor.authorLopez-Ortego, Paloma
dc.contributor.authorArruza, Luis
dc.contributor.authorAvila-Alvarez, Alejandro
dc.contributor.authorMuro, Marta
dc.contributor.authorGutierrez-Gonzalez, Enrique
dc.contributor.authorZozaya, Carlos
dc.contributor.authorSanchez-Helguera, Gema
dc.contributor.authorElorza, Dolores
dc.contributor.authorMartinez-Ramas, Andrea
dc.contributor.authorVillar, Gema
dc.contributor.authorLabrandero, Carlos
dc.contributor.authorMartinez, Lucia
dc.contributor.authorCasado, Teresa
dc.contributor.authorCuadrado, Irene
dc.contributor.authorDel Cerro, Maria Jesus
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2019-05-21T08:55:51Z
dc.date.available2019-05-21T08:55:51Z
dc.date.issued2019
dc.description.abstractINTRODUCTION: Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in childhood, related to prematurity, and the most common cause of pulmonary hypertension (PH) secondary to pulmonary disease in children. Moderate and severe BPD have a worse outcome and relate more frequently with PH. The prediction of moderate or severe BPD development in extremely premature newborns is vital to implement preventive strategies. Starting with the hypothesis that molecular biomarkers were better than clinical and echocardiographic factors, this study aims to explore the ability of clinical, echocardiographic and analytical variables to predict moderate or severe BPD in a cohort of extremely preterm infants. PATIENTS AND METHODS: We designed a prospective longitudinal study, in which we followed a cohort of preterm newborns (gestational age <28 weeks and weight ≤ 1250 grams). In these newborns we recorded weekly clinical and echocardiographic variables as well as blood and tracheal aspirate samples, to analyze molecular biomarkers (IL-6, IL-1, IP10, uric acid, HGF, endothelin-1, VEGF, CCL5). Variables and samples were collected since birth up to week 36 (postmenstrual age), time-point at which the diagnosis of BPD is established. RESULTS: We included 50 patients with a median gestational age of 26 weeks (IQR 25-27) and weight of 871 g (SD 161,0) (range 590-1200g). Three patients were excluded due to an early death. Thirty-five patients (74.5%) developed BPD (mild n = 14, moderate n = 15, severe n = 6). We performed a logistic regression in order to identify risk factors for moderate or severe BPD. We compared two predictive models, one with two variables (mechanical ventilation and inter-ventricular septum flattening), and another-one with an additional molecular biomarker (ET-1). CONCLUSIONS: The combination of clinical and echocardiographic variables is a valuable tool for determining the risk of BPD. We find the two variable model (mechanical ventilation and echocardiographic signs of PH) more practical for clinical and research purposes. Future research on BPD prediction should be oriented to explore the potential role of ET-1.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis study was funded by the Instituto de Salud Carlos III (Plan Estatal de I+D+i) (PI14/00219 and PI15/01100) and cofinanced by the European Development Regional Fund “A way to achieve Europe” (ERDF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.format.number3es_ES
dc.format.pagee0213210es_ES
dc.format.volume14es_ES
dc.identifier.citationPLoS One. 2019 Mar 6;14(3):e0213210.es_ES
dc.identifier.doi10.1371/journal.pone.0213210es_ES
dc.identifier.e-issn1932-6203es_ES
dc.identifier.issn1932-6203es_ES
dc.identifier.journalPloS onees_ES
dc.identifier.pubmedID30840669es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7623
dc.language.isoenges_ES
dc.publisherPublic Library of Science (PLOS)
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI14/00219es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI15/01100es_ES
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0213210es_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidad (ENS)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleExploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasiaes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationaca8d9c7-b6ef-422d-a6a0-9d98135cb948
relation.isAuthorOfPublication.latestForDiscoveryaca8d9c7-b6ef-422d-a6a0-9d98135cb948
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication.latestForDiscoveryefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isPublisherOfPublicationa2759e3d-0d58-4e8a-9fcd-c6130ee333d1
relation.isPublisherOfPublication.latestForDiscoverya2759e3d-0d58-4e8a-9fcd-c6130ee333d1

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ExploringClinicalEchocardiographicAnd_2019.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format
Description: